Affordable Access

Triple antiviral re-therapy for chronic hepatitis C with interferon-alpha, ribavirin and amantadine in nonresponders to interferon-alpha and ribavirin.

Authors
Type
Published Article
Journal
European journal of medical research
Publication Date
Volume
7
Issue
4
Pages
149–154
Identifiers
PMID: 12010649
Source
Medline

Abstract

In patients with a breakthrough or relapse after interferon monotherapy or standard combination therapy with interferon and ribavirin a re-therapy with a triple combination of interferon, ribavirin, and amantadine results in a high rate of sustained virological response.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments